Literature DB >> 16415879

Reconstitution of chromatin transcription with purified components reveals a chromatin-specific repressive activity of p300.

Buyung Santoso1, James T Kadonaga.   

Abstract

Here we describe an in vitro chromatin transcription system in which chromatin assembly and transcription are carried out with purified and defined factors. With basal (also known as general) transcription factors and sequence-specific DNA-binding activators, we observed chromatin-specific, activation domain-dependent transcription. We then examined the biochemical function of purified p300 in the absence of the endogenous factor and other related activities and found, unexpectedly, that p300 has a chromatin-specific, transcriptional repression activity that can be relieved by the addition of acetyl-CoA. This p300-mediated repression is reversible, requires the p300 bromodomain but not the acetyltransferase region, and does not involve the formation of a stable, nuclease-resistant nucleoprotein complex. Hence, the mechanism of transcriptional repression by p300 is distinct from that of histone H1, PARP-1 or Sir2. These findings reveal a novel chromatin-specific repressive function of p300.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415879     DOI: 10.1038/nsmb1048

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  12 in total

1.  Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.

Authors:  Kasey L Konesky; Jennifer K Nyborg; Paul J Laybourn
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.

Authors:  Matthew T Knuesel; Krista D Meyer; Carrie Bernecky; Dylan J Taatjes
Journal:  Genes Dev       Date:  2009-02-15       Impact factor: 11.361

3.  Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.

Authors:  Chun Guo; Qiande Hu; Chunxia Yan; Jinsong Zhang
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

Review 4.  Assembly of the transcription machinery: ordered and stable, random and dynamic, or both?

Authors:  Timothy J Stasevich; James G McNally
Journal:  Chromosoma       Date:  2011-11-03       Impact factor: 4.316

5.  Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.

Authors:  Daniel P Stiehl; Donna M Fath; Dongming Liang; Yubao Jiang; Nianli Sang
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

6.  Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system.

Authors:  Yue Zhao; Ken-ichi Takeyama; Shun Sawatsubashi; Saya Ito; Eriko Suzuki; Kaoru Yamagata; Masahiko Tanabe; Shuhei Kimura; Sally Fujiyama; Takashi Ueda; Takuya Murata; Hiroyuki Matsukawa; Yuko Shirode; Alexander P Kouzmenko; Feng Li; Testuya Tabata; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

7.  Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Authors:  Fabio Stossi; Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

8.  STAMP alters the growth of transformed and ovarian cancer cells.

Authors:  Yuanzheng He; John A Blackford; Elise C Kohn; S Stoney Simons
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

9.  Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen-induced cellular transformation.

Authors:  Andrea Hermannstädter; Christine Ziegler; Marion Kühl; Wolfgang Deppert; Genrich V Tolstonog
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.

Authors:  Zhanyun Tang; Wei-Yi Chen; Miho Shimada; Uyen T T Nguyen; Jaehoon Kim; Xiao-Jian Sun; Toru Sengoku; Robert K McGinty; Joseph P Fernandez; Tom W Muir; Robert G Roeder
Journal:  Cell       Date:  2013-07-18       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.